Cite
HARVARD Citation
Flanagan, M. et al. (n.d.). O12: IHC ANALYSIS OF RESIDUAL DISEASE POST NEOADJUVANT TRASTUZUMAB FOR EARLY STAGE BREAST CANCER REVEALS ER/HER2 CROSSTALK THROUGH INCREASED ER SIGNALLING. British journal of surgery. p. . [Online].